Fernandez Henry A
- SEC CIK
- 0001416750
In the past year, 3 open-market purchase filings worth $12.5M and no sales.
Current role at each company
- MSCI MSCI Inc.Chairman and CEOas of May 18, 2026
- RPRX Royalty Pharma plcDirectoras of Jun 30, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $12.5M
- 3 filings
- Sold
- –
- 0 filings
- Net
- +$12.5M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Fernandez Henry A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MSCI MSCI Inc.
Chairman and CEO9 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 18, 2026 (view filing) | May 15 | 3 days | Fernandez Henry AChairman and CEO | PPurchase | +4.00K | $562.40 | +$2.25M | +0.2%1.73M after | 7 lots |
| Feb 17, 2026 (view filing) | Feb 13-17 | 4 days | Fernandez Henry AChairman and CEO | PPurchase | +6.80K | $523.56 | +$3.56M | +0.5%1.49M after | 4 lots |
| Dec 9, 2025 (view filing) | Dec 5 | 4 days | Fernandez Henry AChairman and CEO | PPurchase | +10.2K | $536.13 | +$5.47M | +0.7%1.49M after | 10 lots |
| Dec 9, 2025 (view filing) | Dec 5 | 4 days | Fernandez Henry AChairman and CEO | PPurchase | +2.29K | $536.17 | +$1.23M | +0.7%335.1K after | 9 lots |
| Jul 28, 2025 (view filing) | Jul 24-25 | 4 days | Fernandez Henry AChairman and CEO | PPurchase | +10.0K | $544.73 | +$5.45M | +0.8%1.28M after | 4 lots |
| Jul 28, 2025 (view filing) | Jul 24 | 4 days | Fernandez Henry AChairman and CEO | PPurchase | +2.40K | $535.11 | +$1.28M | +0.7%332.8K after | |
| Feb 25, 2025 (view filing) | Feb 24 | 1 day | Fernandez Henry AChairman and CEO | PPurchase | +5.30K | $574.51 | +$3.04M | +0.4%1.27M after | 3 lots |
| Dec 9, 2024 (view filing) | Dec 5 | 4 days | Fernandez Henry AChairman and CEO | PPurchase | +2.90K | $612.80 | +$1.78M | +0.9%330.4K after | 3 lots |
| Apr 26, 2024 (view filing) | Apr 25 | 1 day | Fernandez Henry AChairman and CEO | PPurchase | +13.0K | $465.92 | +$6.06M | +4.1%327.5K after | 9 lots |
RPRX Royalty Pharma plc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2022 (view filing) | Feb 24 | 1 day | Fernandez Henry ADirector | PPurchaseClass A Ordinary Shares | +32.5K | $37.49 | +$1.22M | +126.5%58.2K after |